Flipkart on Friday introduced its entry into the healthcare phase and mentioned it has signed an settlement to accumulate a majority stake in Sastasundar Market, a web based pharmacy.
The Walmart-controlled e-commerce agency mentioned it entered into the sector by means of the launch of Flipkart Well being+ and as a part of this improvement, it has signed a definitive settlement to accumulate a majority share in Sastasundar Market.
The Kolkata-headquartered on-line pharmacy owns and operates SastaSundar.com. It presents a digital healthcare and pharmacy platform supported by a community of greater than 490 pharmacies and is backed by buyers from Japan, particularly Mitsubishi Company and Rohto Prescribed drugs.
Flipkart, Senior VP and Head – Company Growth, Ravi Iyer mentioned, “We’re excited to enter this area by means of this funding in SastaSundar.com, an organization that has established itself as a trusted associate for lakhs of customers by means of real merchandise, a technology-powered platform, and a large community.”
Flipkart mentioned its intention is to provide the folks of India reasonably priced and high quality healthcare. Flipkart Well being+, the corporate mentioned, will begin with e-pharmacy and add new healthcare companies together with e-diagnostics and e-consultation sooner or later.
“Flipkart Well being+ will leverage the mixed strengths of the Flipkart Group, which incorporates its pan-India attain and know-how capabilities, with SastaSundar’s deep experience’ to supply customers end-to-end choices within the health-tech ecosystem,” the corporate mentioned in a ready assertion.